Phase II double‐blind, dose‐ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: With analysis of liver and kidney signal change on early and delayed imaging
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.